Equity Overview
Price & Market Data
Price: $2.06
Daily Change: +$0.014 / 0.68%
Daily Range: $2.06 - $2.10
Market Cap: $103,207,440
Daily Volume: 1,379,152
Performance Metrics
1 Week: -2.37%
1 Month: -2.83%
3 Months: 11.35%
6 Months: 5.10%
1 Year: 28.75%
YTD: -0.48%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country:
Details
HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.